Cardiomyopathy causes: Difference between revisions
Jump to navigation
Jump to search
Line 74: | Line 74: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Chemical / poisoning''' | | '''Chemical / poisoning''' | ||
|bgcolor="Beige"| [[Arsenic]], [[cobalt]], endothall, [[ethanol]], [[lead]], [[thallium]] | |||
|bgcolor="Beige"| | |||
[[Arsenic]], | |||
[[cobalt]], | |||
[[endothall]], | |||
[[ethanol]], | |||
[[lead]], | |||
[[thallium]], | |||
<font color="#777777">[[allylamine]],</font> | |||
<font color="#777777">[[carbon monoxide]],</font> | |||
<font color="#777777">[[toxic mushrooms]]</font> | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
|bgcolor="Beige"| Familial cutaneous collagenoma, [[ | |||
|bgcolor="Beige"| | |||
Familial cutaneous collagenoma, | |||
[[lentiginosis]], | |||
[[dermatomyositis]], | |||
[[Carvajal-Huerta syndrome]], | |||
[[Hand-Schuller-Christian syndrome]], | |||
[[McLeod syndrome]], | |||
[[Multiple lentigines syndrome]], | |||
[[Naxos disease]], | |||
[[Pityriasis lichenoides et varioliformis acuta (PLEVA)]], | |||
[[Refsum disease]] | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect'''|bgcolor="Beige"| | ||
|bgcolor="Beige"| | [[5-fluorouracil]], | ||
[[aclarubicin]], | |||
[[actinomycin D]], | |||
[[alemtuzumab]], | |||
[[amrubicin]], | |||
[[bleomycin]], | |||
[[certolizumab pegol]], | |||
[[cisplatin]], | |||
[[clozapine]], | |||
[[cyclophosphamide]], | |||
[[dasatinib]], | |||
[[daunorubicin]], | |||
[[disopyramide]], | |||
[[doxorubicin]], | |||
[[epirubicin]], | |||
[[fenfluramine]], | |||
[[hydralazine]], | |||
[[idarubicin]], | |||
[[imatinib]], | |||
[[interferon-alfa]], | |||
[[mitoxantrone]], | |||
[[paclitaxel]], | |||
[[paracetamol]], | |||
[[pirarubicin]], | |||
[[pixantrone]], | |||
[[streptomycin]], | |||
[[sunitinib]], | |||
[[tacrolimus]], | |||
[[trastuzumab]], | |||
[[tricyclic anti-depressant]] abuse, | |||
[[valrubicin]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" |
Revision as of 17:11, 9 August 2013
Cardiomyopathy Microchapters |
Diagnosis |
---|
Treatment |
Guidelines |
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
Case Studies |
Cardiomyopathy causes On the Web |
American Roentgen Ray Society Images of Cardiomyopathy causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
There is a very wide range of factors that can cause cardiomyopathy, ranging from infectious causes, toxins, genetic causes and other disease processes.
Causes
Common Causes
- Beri-Beri (thiamine or vitamin B1)
- Cocaine abuse
Causes by Organ System
Causes in Alphabetical Order
Genetic Causes of Cardiomyopathy
Phenotype | Inheritance Pattern | Chromosomal Locus | Gene | Protein | Skeletal Myopathy |
---|---|---|---|---|---|
Dilated cardiomyopathy | X-linked | Xp21 | dystrophin | Dystrophin | Duchenne / Becker muscular dystrophy |
X-linked | Xq28 | G4.5 | Tafazzin | Barth syndrome | |
Autosomal dominant | 15q14 | actin | Actin | Nemaline myopathy | |
2q35 | desmin | Desmin | Desmin myopathy | ||
5q33 | δ-sarcoglycan | δ-sarcoglycan | Limb girdle muscular dystrophy 2F | ||
1q32 | Troponin T | Troponin T | |||
14q11 | β-myosin heavy chain | β-myosin heavy chain | |||
15q2 | α-tropomyosin | α-tropomyosin | Nemaline myopathy | ||
Midna | Mitochondrial respiratory chain | Mitochondrial respiratory chain | Mitochondrial myopathy | ||
Dilated cardiomyopathy with conduction disease | Autosomal dominant | 1q21 | lamin A/C | Lamin A/C | Emery-Dreifuss muscular dystrophy |
Hypertrophic cardiomyopathy | Autosomal dominant | 14q11 | β-myosin heavy chain | β-myosin heavy chain | |
14q11 | β-myosin heavy chain | β-myosin heavy chain | |||
1q32 | Troponin T | Troponin T | |||
12q23 | Troponin T | Troponin T | |||
15q2 | α-tropomyosin | α-tropomyosin | Nemaline myopathy | ||
11q11 | myosin-binding protein C | myosin-binding protein C | |||
3p21 | myosin essential light chain | myosin essential light chain | |||
3p21 | myosin regulatory light chain | myosin regulatory light chain | |||
2p31 | titin | Titin | |||
Hypertrophic cardiomyopathy with Wolf-Parkinson-White syndrome | 7q3 | AMPK | AMPK | ||
MIDINA | Mitochondrial respiratory chain | Mitochondrial respiratory chain | Mitochondrial myopathy | ||
Left ventricular noncompaction | X-linked | Xq28 | G4.5 | Tafazzin | Barth syndrome |
Autosomal dominant | 18q12 | α-dystrobrevin | α-dystrobrevin | Muscular dystrophy |
Table from article *"The Failing Heart". Nature. June 15, 2007